company background image
HMD logo

HeraMED ASX:HMD Stock Report

Last Price

AU$0.015

Market Cap

AU$12.3m

7D

3.6%

1Y

n/a

Updated

17 Apr, 2025

Data

Company Financials

HeraMED Limited

ASX:HMD Stock Report

Market Cap: AU$12.3m

HMD Stock Overview

A medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. More details

HMD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Risk Analysis

Earnings have declined by 6.5% per year over past 5 years

Has less than 1 year of cash runway

Makes less than USD$1m in revenue (A$364K)

Shareholders have been substantially diluted in the past year

+ 2 more risks

HeraMED Limited Competitors

Resonance Health

ASX:RHT

AU$18.4m

Control Bionics

ASX:CBL

AU$13.8m

CardieX

ASX:CDX

AU$24.3m

Universal Biosensors

ASX:UBI

AU$18.5m

Price History & Performance

Summary of share price highs, lows and changes for HeraMED
Historical stock prices
Current Share PriceAU$0.015
52 Week HighAU$0.031
52 Week LowAU$0.013
Beta0.28
1 Month Change11.54%
3 Month Change-19.44%
1 Year Changen/a
3 Year Change-89.64%
5 Year Change-88.85%
Change since IPO-91.94%

Recent News & Updates

Recent updates

Shareholder Returns

HMDAU Medical EquipmentAU Market
7D3.6%3.8%5.4%
1Yn/a-14.5%-0.02%

Return vs Industry: Insufficient data to determine how HMD performed against the Australian Medical Equipment industry.

Return vs Market: Insufficient data to determine how HMD performed against the Australian Market.

Price Volatility

Is HMD's price volatile compared to industry and market?
HMD volatility
HMD Average Weekly Movement12.6%
Medical Equipment Industry Average Movement11.3%
Market Average Movement9.1%
10% most volatile stocks in AU Market16.6%
10% least volatile stocks in AU Market4.1%

Stable Share Price: HMD's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: HMD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.

Community vs My Fair Value

Select a narrative for quick price alerts from the community, or create your own.

About the Company

FoundedEmployeesCEOWebsite
2011n/aAnoushka Gungadinwww.hera-med.com

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers.

HeraMED Limited Fundamentals Summary

How do HeraMED's earnings and revenue compare to its market cap?
HMD fundamental statistics
Market capAU$12.26m
Earnings (TTM)-AU$5.49m
Revenue (TTM)AU$364.33k

34.8x

P/S Ratio

-2.3x

P/E Ratio

Is HMD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HMD income statement (TTM)
RevenueAU$364.33k
Cost of RevenueAU$145.75k
Gross ProfitAU$218.58k
Other ExpensesAU$5.71m
Earnings-AU$5.49m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0063
Gross Margin60.00%
Net Profit Margin-1,507.04%
Debt/Equity Ratio3.0%

How did HMD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/17 09:02
End of Day Share Price 2025/04/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HeraMED Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.